Pangali rega marang bathi Anavex (AVXL)
Drug synthesis automation requires expenditures that impact the debt load, and the current price-to-earnings valuation visualizes these costs. The -6.50 indicator determines the magnitude of the metric on the chart. Optimization is possible through a future patent monopoly and high profitability upon FDA approval of drugs for Alzheimer's patients, which will provide Anavex Life Sciences (AVXL) with a colossal scale effect.
Rincian analitis perusahaan Anavex Life Sciences Corp. (AVXL)
- rega lan prakiraan konsensus rega:
- rincian kapitalisasi pasar:
- statistik nilai buku emiten:
- informasi babagan utang lan solvabilitas:
Utang marang Modal Anavex Life Sciences|AVXL - Rasio utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang modal Anavex Life Sciences Corp.|AVXL - Gunggung utang perusahaan|Rasio utang marang aset resik Anavex Corp|AVXL - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Anavex Life Sciences|Koefisien jangkoan perantara anavex.com
- data bathi resik lan rasio valuasi:
AVXL - Bathi resik|Bathi forward Anavex Life Sciences|AVXL - Pangali P/E|Rasio prakiraan rega marang bathi Anavex Life Sciences|AVXL - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Anavex Corp|AVXL - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone patang kuartal pungkasan Anavex Life Sciences|AVXL - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan anavex.com|AVXL - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Anavex Life Sciences
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:Anavex - AVXL
The P/E ratio measures a business's market value relative to its net income, allowing an investor to assess the extent of overpayment for an asset or the risk of margin compression. When analyzing the P/E ratio dynamics of Anavex Life Sciences (AVXL), it is critical to consider biotech specifics: high R&D costs for CNS disease treatments can temporarily distort the multiple, necessitating caution when determining actual investment attractiveness.
Analisis perusahaan pesaing
Rasio rega marang bathi BIIB|Pangali P/E NBIX|Regencell (RGC) - Rasio kapitalisasi marang bathi resik|Rasio rega marang bathi axsome.com AXSM|Pangali P/E ACADIA Pharmaceuticals ACAD|XENE - Rasio rega marang bathi|Periode bali modal bisnis Viking Therapeutics Inc VKTX|Supernus Pharma (SUPN) - Rasio rega marang bathi|CPRX (Catalyst Pharmaceuticals) - Rasio rega marang bathi|DNLI (denalitherapeutics.com) - Pangali P/E|Pangali rega marang bathi HRMY (Harmony Biosciences Holdings, Inc.)|Pangali P/E BHVN|AMLX (Amylyx Pharmaceuticals Inc) - Nilai perusahaan marang bathi resik|Pangali P/E TRVI (Trevi Pharma)|PRAX (Praxis Corp) - Kapitalisasi marang bathi resik|CBLL: Koefisien rega marang bathi|Nilai perusahaan marang bathi resik PRTA (prothena.com)|Alector, Inc. (ALEC) - Rasio rega marang bathi|Pangali rega marang bathi ANNX|Rasio rega marang bathi Omeros Corp.|Neurogene Therapeutics (NGNE) - Periode bali modal bisnis|Pangali P/E ACIU|VYGR (Voyager Therapeutics) - Nilai perusahaan marang bathi resik|Pangali P/E NMRA (neumoratx.com)|SCLX: Pangali rega marang bathi|TVGN - Rasio rega marang bathi|Kapitalisasi marang bathi Alpha Cognition Inc.|CGTX: Pangali P/E|inhibikase.com (IKT) - Pangali P/E|Rasio rega marang bathi Cassava Sciences Inc|ASRT - Rasio kapitalisasi marang bathi resik|Rasio rega marang bathi Coya (COYA)|Pangali P/E VistaGen Therapeutics Inc (VTGN)|Ovid Therapeutics Inc. - Koefisien rega marang bathi|Periode bali modal bisnis Acumen Pharmaceuticals (ABOS)|CervoMed Corporation - Pangali P/E|Periode bali modal bisnis alteritytherapeutics.com ATHE|CLNN: Pangali P/E|Kapitalisasi marang bathi PepGen Corp (PEPG)|Rasio rega marang bathi Jupiter Neurosciences, Inc.|RLMD: Nilai perusahaan marang bathi resik|Pangali P/E ANVS|Koefisien rega marang bathi Grace Tx GRCE|Rasio rega marang bathi Firefly Neuroscience, Inc AIFF|KLTO: Pangali rega marang bathi|NRSN - Rasio rega marang bathi|RVPH: Rasio rega marang bathi|MTVA (MetaVia Inc.) - Koefisien rega marang bathi|NeurAxis Inc. (NRXS) - Pangali P/E|Rasio rega marang bathi Helius Medical|Passage Bio, Inc. - Kapitalisasi marang bathi resik|Koefisien rega marang bathi NEUP (Neuphoria)|NERV - Kapitalisasi marang bathi|Pangali P/E ATHA (athira.com)|Pangali P/E Addex Therapeutics Ltd ADXN|Alzamend Neuro, Inc. - Pangali P/E|CYCN - Pangali P/E|PTIX (Protagenic Therapeutics, Inc.) - Koefisien rega marang bathi|Kapitalisasi marang bathi Pasithea (KTTA)|Rasio rega marang bathi Cortigent|Kapitalisasi marang bathi Avenue Therapeutics Inc. ATXI|Rasio rega marang bathi brainstorm-cell.com (BCLI)|Koefisien rega marang bathi Cara Therapeutics, Inc CARA|Pangali P/E CHRO (chromocell.com)|Nilai perusahaan marang bathi resik ELYM|Intra-Cellular Therapies Inc. - Pangali P/E|Kapitalisasi marang bathi Longboard Pharmaceuticals Inc|Marinus (MRNS) - Rasio rega marang bathi|NKGN - Periode bali modal bisnis|Rasio rega marang bathi NeuroBo Pharmaceuticals|SAGE: Nilai perusahaan marang bathi resik|Pangali P/E SNPX|Trevena Inc. - Pangali rega marang bathi|Rasio rega marang bathi Vigil Neuroscience, Inc. VIGL|Anew Medical, Inc. - Rasio rega marang bathi|Cerevel Therapeutics - Pangali P/E
